Cetuximab: a critical appraisal of a novel development in the treatment of squamous cell carcinoma of the head and neck

Publisher： Cambridge University Press

E-ISSN： 1467-1131|7|1|1-7

ISSN： 1460-3969

Source： Journal of Radiotherapy in Practice, Vol.7, Iss.1, 2008-03, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck

By Levy Adrian R.   Johnston Karissa M.   Sambrook Jennifer   Donato Bonnie   Penrod John R.   Corral Mitra   Chasen Martin  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2253-2259

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck

By  

Case Reports in Oncology, Vol. 8, Iss. 3, 2015-11 ,pp. : 503-508

Karger

Access to resources Recommend Favorite

Incidence of mucositis in patients with head and neck squamous cell carcinoma treated with radiotherapy plus cetuximab: a pilot study

By Bodard Anne-Gaëlle   Hrifach Abdelbaste   Salino Samuel   Fabris Matthieu   Desoutter Aline   Pommier Pascal   Fayette Jérôme  

Médecine Buccale - Chirurgie Buccale, Vol. 18, Iss. 3, 2012-09 ,pp. : 181-185

Edp Sciences

Access to resources Recommend Favorite

Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 290-296

Karger

Access to resources Recommend Favorite

Prognostic Factors in Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 25, Iss. 3, 2002-07 ,pp. : 208-212

Karger

Access to resources Recommend Favorite